| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 7,997 | 5,718 | 7,070 | | Cost of Revenue | 2,160 | 1,965 | 2,859 | | | Gross Profit | 5,837 | 3,753 | 4,211 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,933 | 6,144 | 7,031 | | Non Recurring |
-
| 10,113 |
-
| | Others | 187 | 181 | 144 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 717 | (12,686) | (2,965) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 344 | 1,517 | (92) | | Earnings Before Interest And Taxes | 1,061 | (11,169) | (3,057) | | Interest Expense | 3,046 | 506 | 249 | | Income Before Tax | (1,984) | (11,675) | (3,306) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,984) | (11,675) | (3,306) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,984) | (11,675) | (3,306) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,984) | ($11,675) | ($3,306) |
|
0.22% Nasdaq 
0.02 (10.00%) 
Income Statement
